3 Colo. Code Regs. § 719-1-A
(Appendix A)
This collaborative pharmacy practice statewide protocol authorizes qualified Colorado-licensed pharmacists ("Pharmacists") to perform the pertinent physical assessments and prescribe contraceptives under the conditions of this protocol and according to and in compliance with all applicable state and federal laws and rules.
Definitions
(1) "Clinical visit" means a consultation with a healthcare provider, other than a pharmacist, for women's health, which should address contraception and age-appropriate screening.
(2) "Hormonal contraceptive patch" means a transdermal patch applied to the skin of a patient, by the patient or by a practitioner, that releases a drug composed of a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy.
(3) "Oral hormonal contraceptive" means a drug composed of a hormone or a combination of hormones that is approved by the United States Food and Drug Administration to prevent pregnancy and that the patient to whom the drug is prescribed may take orally.
(4) "Vaginal ring" means a plastic ring, inserted vaginally by the patient that releases a combination or hormones that is approved by the United States Food and Drug Administration to prevent pregnancy.
(5) "DPMA" means Depot Medroxyprogesterone Acetate, an injection, administered every three months by a pharmacist of patient that is approved by the United States Food and Drug Administration to prevent pregnancy.
Training Program
Only a Colorado-licensed pharmacist, who has completed an Accreditation Council for Pharmacy Education (ACPE) accredited educational training program related to the prescribing of contraceptives by a pharmacist may, if clinically appropriate, prescribe, dispense, or administer hormonal contraceptives to a patient. In addition, pharmacists shall comply with the most current United States Medical Eligibility Criteria (USMEC) for Contraceptive Use as adopted by the U.S. Centers for Disease Control and Prevention (CDC).
Age Requirements
A pharmacist may prescribe hormonal contraceptives to a person who is at least 18 years of age.
Further Conditions
(1) For each new patient requesting a contraceptive service and, at a minimum of every twelve months for each returning patient, a participating pharmacist must:
(a) Obtain a completed patient self-screening risk-assessment questionnaire;
(b) Assess what contraceptive options are appropriate for the patient through a consistent and standardized process;
(c) May prescribe, if clinically appropriate, the hormonal contraceptive patch, self-administered oral hormonal contraceptive, DMPA, Vaginal Ring, or refer to a healthcare practitioner;
(d) Provide the patient with a visit summary;
(e) Advise the patient to consult with a primary care practitioner or women's health care practitioner;
(f) Refer any patient that may be subject to abuse to an appropriate social services agency; and
(g) Ensure that the pharmacy provides appropriate space to prevent the spread of infection and provide appropriate consultation and ensure confidentiality.
(2) If the contraceptive is dispensed or administered, it must be done as soon as practicable after the pharmacist issues the prescription and shall include any relevant educational materials.
(3) A pharmacist must not:
(a) Require a patient to schedule an appointment with the pharmacist for the prescribing or dispensing of a hormonal contraceptive;
(b) Continue to prescribe and dispense a hormonal contraceptive to a patient beyond three years from the initial prescription without evidence of a clinical visit; or
(c) Prescribe in instances when referral to a primary care provider is more appropriate.
(4) Records:
(a) Pursuant to Pharmacy Rule 17.00.50, a process shall be in place for the pharmacist to communicate with the patient's primary care provider and document changes to the patient's medical record. If the patient does not have a primary care provider, or is unable to provide contact information for his or her primary care provider, the pharmacist shall provide the patient with a written record of the drugs or devices furnished and advise the patient to consult an appropriate health care professional of the patient's choice.
(b) Pharmacists shall comply with all aspects of Pharmacy Rules 17.01.00 and 17.02.00 with respect to the maintenance of proper records.
Remove all subsequent pages. Consider where additional resources might exist. Consider linking to the US MEC.
3 CCR 719-1-A